# LEESAR, INC – FDA Inspection, Jul 12, 2017

Source: https://www.keypedia.com/records/fda_inspections/leesar-inc/1c0f6637-7e3e-41a6-ad64-e474ec2bb395
Source feed: FDA_Inspections

> FDA inspection 1017863 of LEESAR, INC, July 12, 2017. Classification: Official Action Indicated (OAI). 5 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1017863
- Company Name: LEESAR, INC
- Inspection Date: 2017-07-12
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1337198 - 2026-09-23](https://www.keypedia.com/records/fda_inspections/leesar-inc/e4951ec0-3f11-4759-94f5-93eaf99c3861)
- [FDA Inspection 1276435 - 2025-07-18](https://www.keypedia.com/records/fda_inspections/leesar-inc/e2518a78-6f9f-4717-bb49-3bbfe1b7d059)
- [FDA Inspection 1269588 - 2025-05-09](https://www.keypedia.com/records/fda_inspections/leesar-inc/5b5e6da8-89f6-4626-8c6e-8ccebe6bbb3d)
- [FDA Inspection 1155647 - 2021-10-29](https://www.keypedia.com/records/fda_inspections/leesar-inc/32d81905-7783-4221-af38-992e00ec4a4b)
- [FDA Inspection 893985 - 2014-08-08](https://www.keypedia.com/records/fda_inspections/leesar-inc/0f0196ac-2de9-4b44-9c2a-36f8aef0541b)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/ian-f-deveau/81581024-352f-40f2-9060-92ac321b87ad)
- [FDA Associated Person](https://www.keypedia.com/people/jennifer-lalama/5ebc4da1-62ac-4b15-89a8-e18b0606e0ff)
- [FDA Associated Person](https://www.keypedia.com/people/june-p-page/3b1ffc71-ce2e-47f5-aefe-87fd5eebc792)
- Issuing Officer

Company: https://www.keypedia.com/companies/leesar-inc/275b969d-7cd2-4c17-af66-d7ed6ff4dec1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
